Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Moodys
Merck
Mallinckrodt
AstraZeneca

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Cadila Pharms Ltd Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for CADILA PHARMS LTD, and what generic and branded alternatives to CADILA PHARMS LTD drugs are available?

CADILA PHARMS LTD has nineteen approved drugs.



Summary for Cadila Pharms Ltd
US Patents:0
Tradenames:17
Ingredients:17
NDAs:19

Drugs and US Patents for Cadila Pharms Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cadila Pharms Ltd VERAPAMIL HYDROCHLORIDE verapamil hydrochloride TABLET, EXTENDED RELEASE;ORAL 206173-001 May 5, 2017 AB RX No No   Start Trial   Start Trial
Cadila Pharms Ltd VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET;ORAL 206250-005 Nov 21, 2018 AB RX No No   Start Trial   Start Trial
Cadila Pharms Ltd ROSUVASTATIN CALCIUM rosuvastatin calcium TABLET;ORAL 207453-002 Nov 23, 2016 AB RX No No   Start Trial   Start Trial
Cadila Pharms Ltd VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 211323-001 Aug 29, 2019 AB RX No No   Start Trial   Start Trial
Cadila Pharms Ltd RIVASTIGMINE TARTRATE rivastigmine tartrate CAPSULE;ORAL 203844-003 Feb 13, 2017 AB RX No No   Start Trial   Start Trial
Cadila Pharms Ltd TIZANIDINE HYDROCHLORIDE tizanidine hydrochloride CAPSULE;ORAL 210021-002 Mar 26, 2019 AB RX No No   Start Trial   Start Trial
Cadila Pharms Ltd OFLOXACIN ofloxacin TABLET;ORAL 091656-002 Sep 18, 2014 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Merck
AstraZeneca
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.